Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obesity
  Free Subscription

Articles published in
Metabolism
    December 2025
  1. GIANNAKOGEORGOU A, Kahl S, Granata C, Heilmann G, et al
    Relationship of GDF15 with hepatic mitochondrial respiration is depending on the presence of fibrosis in obese individuals.
    Metabolism. 2025;173:156391.
    >> Share

  2. GUO DF, Luo Z, Olson A, Morgan DA, et al
    SerpinA3N in leptin-sensitive neurons is required for energy and glucose homeostasis and autonomic regulation.
    Metabolism. 2025;173:156387.
    >> Share

    October 2025
  3. ASHLAW EF, Elfers CT, Chichura KS, Miranda IC, et al
    A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity.
    Metabolism. 2025 Oct 13:156414. doi: 10.1016/j.metabol.2025.156414.
    >> Share

    September 2025
  4. PHILIPPE MA, Fruchet B, Cagninacci L, Beaudoin L, et al
    BMAL2 controls adipose tissue inflammation and metabolic adaptation during obesity.
    Metabolism. 2025 Sep 20:156396. doi: 10.1016/j.metabol.2025.156396.
    >> Share

  5. DOS REIS ARAUJO T, da Silva Junior JA, Alves BL, Guimaraes DSPSF, et al
    Disruption of mitochondria-associated membranes contributes to the dysregulation of insulin secretion in undernutrition, obesity, and double burden of malnutrition.
    Metabolism. 2025 Sep 15:156393. doi: 10.1016/j.metabol.2025.156393.
    >> Share

  6. LIU J, Oliverio A, Godlewski G, Kocvarova R, et al
    Hepatic CB1 receptor signaling triggers G(i/o)alpha-mediated lipolysis in lean mice but G(s)alpha-mediated lipogenesis in obese mice.
    Metabolism. 2025;170:156308.
    >> Share

  7. CUTHBERTSON DJ, Kennedy OJ, Bilson J, Hydes TJ, et al
    Impact of metabolic dysfunction severity in steatotic liver disease and its interaction with liver fibrosis on all-cause mortality and multiple hepatic and extra-hepatic outcomes.
    Metabolism. 2025;170:156306.
    >> Share

  8. BHATTACHARJEE P, Dvoracsko S, Pointeau O, Kundu B, et al
    Evaluation of tetrahydropyridazine-based peripherally restricted dual inhibitors of CB1R and inducible nitric oxide synthase (iNOS) for treating metabolic syndrome disorders.
    Metabolism. 2025;170:156291.
    >> Share

    August 2025
  9. ZHANG XD, Zhong YS, Yan H, Jin LH, et al
    Chemical discovery of a novel MD2/ADAM17 dual-target inhibitor as a potential therapeutic candidate for saturated fatty acid-induced myocardial inflammatory injury.
    Metabolism. 2025;169:156298.
    >> Share

  10. LEE YH, Lee J, Jeong J, Park K, et al
    Hepatic miR-93 promotes the pathogenesis of metabolic dysfunction-associated steatotic liver disease by suppressing SIRT1.
    Metabolism. 2025;169:156266.
    >> Share

  11. MUND C, Sinha A, Aderhold A, Mateska I, et al
    A key role of polyamine metabolism in adipose tissue homeostasis that regulates obesity.
    Metabolism. 2025 Aug 1:156358. doi: 10.1016/j.metabol.2025.156358.
    >> Share

    July 2025
  12. EL KOUCHE S, Meyre D
    Natural selection signatures of 65 syndromic and 8 monogenic obesity genes in 7 ethnic groups do not support the thrifty genotype hypothesis.
    Metabolism. 2025 Jul 23:156353. doi: 10.1016/j.metabol.2025.156353.
    >> Share

  13. KASAHARA K, Ichikawa Y, Hironaka J, Shinozaki T, et al
    Time for a change? Threshold for obesity in contemporary Japanese population.
    Metabolism. 2025 Jul 15:156352. doi: 10.1016/j.metabol.2025.156352.
    >> Share

    June 2025
  14. KATSAROU A, Papadopoulos G, Moustakas II, Papadopetraki A, et al
    Exercise mitigates liver senescence but does not outmatch dietary restriction in obesity-related MASLD.
    Metabolism. 2025 Jun 10:156325. doi: 10.1016/j.metabol.2025.156325.
    >> Share

  15. HINDSO M, Lundsgaard A, Marinkovic B, Jensen MH, et al
    Fat absorption and metabolism after Roux-en-Y gastric bypass surgery.
    Metabolism. 2025;167:156189.
    >> Share

    May 2025
  16. GALAN A, Garcia-Garcia F
    Revisiting gender differences in obesity and type 2 diabetes: Response letter.
    Metabolism. 2025 May 29:156307. doi: 10.1016/j.metabol.2025.156307.
    >> Share

  17. SON YL, Hou J, Kato-Suzuki M, Okamatsu-Ogura Y, et al
    Corrigendum to "Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction" [Metabolism 168 (2025) 156235].
    Metabolism. 2025;170:156299.
    >> Share

  18. ZHU H, Yi X, He M, Wu S, et al
    Exploring the interplay of genetic variants and environmental factors in childhood obesity: A systematic review and meta-analysis.
    Metabolism. 2025;170:156303.
    >> Share

    April 2025
  19. LENG S, Zhang X, Zhao R, Jiang N, et al
    Mechanical activation of adipose tissue macrophages mediated by Piezo1 protects against diet-induced obesity by regulating sympathetic activity.
    Metabolism. 2025 Apr 7:156262. doi: 10.1016/j.metabol.2025.156262.
    >> Share

  20. ZHONG Y, Wei J, Jiang R
    Revisiting gender differences in obesity and type 2 diabetes: Letter to the editor.
    Metabolism. 2025 Apr 3:156260. doi: 10.1016/j.metabol.2025.156260.
    >> Share

    March 2025
  21. MOLDOVAN RA, Hidalgo MR, Castane H, Jimenez-Franco A, et al
    Landscape of sex differences in obesity and type 2 diabetes in subcutaneous adipose tissue: a systematic review and meta-analysis of transcriptomics studies.
    Metabolism. 2025 Mar 27:156241. doi: 10.1016/j.metabol.2025.156241.
    >> Share

  22. RIBAS-LATRE A, Hoffmann A, Gebhardt C, Weiner J, et al
    The serine protease KLK7 promotes immune cell infiltration in visceral adipose tissue in obesity.
    Metabolism. 2025;168:156239.
    >> Share

  23. SON YL, Hou J, Kato-Suzuki M, Okamatsu-Ogura Y, et al
    Eva1 deficiency prevents obesity-induced metabolic disorders by reducing visceral adipose dysfunction.
    Metabolism. 2025 Mar 19:156235. doi: 10.1016/j.metabol.2025.156235.
    >> Share

  24. ZHANG T, Ren Z, Mao R, Yi W, et al
    LINC00278 and BRG1: A key regulatory axis in male obesity and preadipocyte adipogenesis.
    Metabolism. 2025 Mar 17:156194. doi: 10.1016/j.metabol.2025.156194.
    >> Share

  25. KARAKASIS P, Patoulias D, Fragakis N, Mantzoros CS, et al
    Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis.
    Metabolism. 2025;164:156113.
    >> Share

  26. ZENG X, Wang Y, Farias K, Rappa A, et al
    NRH, a potent NAD(+) enhancer, improves glucose homeostasis and lipid metabolism in diet-induced obese mice through an active adenosine kinase pathway.
    Metabolism. 2025;164:156110.
    >> Share

    January 2025
  27. HU Y, Hai J, Ti Y, Kong B, et al
    Adipose ZFP36 protects against diet-induced obesity and insulin resistance.
    Metabolism. 2025;164:156131.
    >> Share

  28. HE Y, Zhang C, Wu S, Li K, et al
    Central NUCB2/nesfatin-1 signaling ameliorates liver steatosis through suppression of endoplasmic reticulum stress in the hypothalamus.
    Metabolism. 2025;162:156046.
    >> Share

    December 2024
  29. MELA V, Martin-Reyes F, Oliva-Olivera W, Cantarero-Cuenca A, et al
    Serum miR-365b-5p/miR-222-5p as a potential diagnostic biomarker for long-term weight loss in patients with morbid obesity after bariatric surgery.
    Metabolism. 2024 Dec 30:156129. doi: 10.1016/j.metabol.2024.156129.
    >> Share

  30. PERAKAKIS N, Mantzoros CS
    Evidence from clinical studies of leptin: current and future clinical applications in humans.
    Metabolism. 2024;161:156053.
    >> Share

  31. STEFANAKIS K, Kokkorakis M, Mantzoros CS
    The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation.
    Metabolism. 2024;161:156057.
    >> Share

  32. MUNZBERG H, Heymsfield SB, Berthoud HR, Morrison CD, et al
    History and future of leptin: Discovery, regulation and signaling.
    Metabolism. 2024;161:156026.
    >> Share

    November 2024
  33. BUCHWALD LM, Neess D, Hansen D, Doktor TK, et al
    Body weight control via protein kinase CK2: diet-induced obesity counteracted by pharmacological targeting.
    Metabolism. 2024;162:156060.
    >> Share

  34. ZHANG H, Zhou XD, Shapiro MD, Lip GYH, et al
    Global burden of metabolic diseases, 1990-2021.
    Metabolism. 2024;160:155999.
    >> Share

    October 2024
  35. CONFORTO R, Rizzo V, Russo R, Mazza E, et al
    Advances in body composition and gender differences in susceptibility to frailty syndrome: Role of osteosarcopenic obesity.
    Metabolism. 2024 Oct 26:156052. doi: 10.1016/j.metabol.2024.156052.
    >> Share

  36. SERRANO J, Kondo S, Link GM, Brown IS, et al
    A partial loss-of-function variant (Ile191Val) of the TAS1R2 glucose receptor is associated with enhanced responses to exercise training in older adults with obesity: A translational study.
    Metabolism. 2024 Oct 9:156045. doi: 10.1016/j.metabol.2024.156045.
    >> Share

    September 2024
  37. XIE Z, Zheng G, Liang Z, Li M, et al
    Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.
    Metabolism. 2024 Sep 19:156038. doi: 10.1016/j.metabol.2024.156038.
    >> Share

  38. BAGHERI M, Tanriverdi K, Iafrati MD, Mosley JD, et al
    Characterization of the plasma metabolome and lipidome in response to sleeve gastrectomy and gastric bypass surgeries reveals molecular patterns of surgical weight loss.
    Metabolism. 2024;158:155955.
    >> Share

    August 2024
  39. LIM JH, Kim Y, Kim MY, Kim EN, et al
    Placental growth factor deficiency initiates obesity- and aging-associated metabolic syndrome.
    Metabolism. 2024 Aug 20:156002. doi: 10.1016/j.metabol.2024.156002.
    >> Share

    July 2024
  40. RICHTER MM, Kemp IM, Heeboll S, Winther-Sorensen M, et al
    Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.
    Metabolism. 2024;156:155915.
    >> Share

    June 2024
  41. JOLLET M, Tramontana F, Jiang LQ, Borg ML, et al
    Diacylglycerol kinase delta overexpression improves glucose clearance and protects against the development of obesity.
    Metabolism. 2024 Jun 4:155939. doi: 10.1016/j.metabol.2024.155939.
    >> Share

    May 2024
  42. HUTTASCH M, Roden M, Kahl S
    Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
    Metabolism. 2024 May 21:155937. doi: 10.1016/j.metabol.2024.155937.
    >> Share

  43. AVENDANO MS, Perdices-Lopez C, Guerrero-Ruiz Y, Ruiz-Pino F, et al
    The evolutionary conserved miR-137/325 tandem mediates obesity-induced hypogonadism and metabolic comorbidities by repressing hypothalamic kisspeptin.
    Metabolism. 2024 May 8:155932. doi: 10.1016/j.metabol.2024.155932.
    >> Share

  44. NEDELCUT S, Axer S, Olbers T
    The risk and benefit of revisional vs. primary metabolic- bariatric surgery and drug therapy - A narrative review.
    Metabolism. 2024;154:155799.
    >> Share

    April 2024
  45. ZELJKOVIC A, Vekic J, Stefanovic A
    Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
    Metabolism. 2024;156:155919.
    >> Share

  46. AWAZAWA M, Matsushita M, Nomura I, Kobayashi N, et al
    Imeglimin improves systemic metabolism by targeting brown adipose tissue and gut microbiota in obese model mice.
    Metabolism. 2024;153:155796.
    >> Share

  47. ROSENDO-SILVA D, Gomes PB, Rodrigues T, Viana S, et al
    Clinical and molecular profiling of human visceral adipose tissue reveals impairment of vascular architecture and remodeling as an early hallmark of dysfunction.
    Metabolism. 2024;153:155788.
    >> Share

    March 2024
  48. PENDERGRAST LA, Ashcroft SP, Ehrlich AM, Treebak JT, et al
    Metabolic plasticity and obesity-associated changes in diurnal postexercise metabolism in mice.
    Metabolism. 2024 Mar 11:155834. doi: 10.1016/j.metabol.2024.155834.
    >> Share

  49. MENG M, Cao Y, Qiu J, Shan G, et al
    Zinc finger protein ZNF638 regulates triglyceride metabolism via ANGPTL8 in an estrogen dependent manner.
    Metabolism. 2024;152:155784.
    >> Share

  50. KOKKINOS A, Tsilingiris D, Simati S, Stefanakis K, et al
    Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study.
    Metabolism. 2024;152:155773.
    >> Share

  51. REGMI P, Young M, Minigo G, Milic N, et al
    Photoperiod and metabolic health: evidence, mechanism, and implications.
    Metabolism. 2024;152:155770.
    >> Share

  52. LAVILLE M, Robert M, Segrestin B
    Barriers to metabolic surgery and how to address them.
    Metabolism. 2024;152:155764.
    >> Share

    February 2024
  53. RACHELLE H, Malak G, Houry P, Marc H, et al
    Mortality risk in patients with obesity and COVID-19 infection: a systematic review and meta-analysis.
    Metabolism. 2024 Feb 13:155812. doi: 10.1016/j.metabol.2024.155812.
    >> Share

  54. SARABHAI T, Kahl S, Gancheva S, Mastrototaro L, et al
    Loss of mitochondrial adaptation associates with deterioration of mitochondrial turnover and structure in metabolic dysfunction-associated steatotic liver disease.
    Metabolism. 2024;151:155762.
    >> Share

  55. SAMARASINGHE SNS, Woods C, Miras AD
    Bariatric Surgery in Women with Polycystic Ovary Syndrome.
    Metabolism. 2024;151:155745.
    >> Share

  56. TSILINGIRIS D, Kokkinos A
    Advances in obesity pharmacotherapy; learning from metabolic surgery and beyond.
    Metabolism. 2024;151:155741.
    >> Share

  57. MURPHY E, Finucane FM
    Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients.
    Metabolism. 2024;151:155739.
    >> Share

  58. BAUZA-THORBRUGGE M, Vujicic M, Chanclon B, Palsdottir V, et al
    Adiponectin stimulates Sca1(+)CD34(-)-adipocyte precursor cells associated with hyperplastic expansion and beiging of brown and white adipose tissue.
    Metabolism. 2024;151:155716.
    >> Share

    January 2024
  59. FUKUSHIMA T, Maetani T, Chubachi S, Tanabe N, et al
    Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity.
    Metabolism. 2024;150:155715.
    >> Share

  60. ZIQUBU K, Dludla PV, Mabhida SE, Jack BU, et al
    Brown adipose tissue-derived metabolites and their role in regulating metabolism.
    Metabolism. 2024;150:155709.
    >> Share

    October 2023
  61. KATSAROU A, Kouvari M, Hill MA, Mantzoros CS, et al
    Metabolically unhealthy obesity, sarcopenia and their interactions in obesity pathophysiology and therapeutics: Room for improvement in pharmacotherapy.
    Metabolism. 2023 Oct 27:155714. doi: 10.1016/j.metabol.2023.155714.
    >> Share

  62. STEINBACH E, Masi D, Ribeiro A, Serradas P, et al
    Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation.
    Metabolism. 2023 Oct 24:155712. doi: 10.1016/j.metabol.2023.155712.
    >> Share

  63. KARAKASIS P, Patoulias D, Pamporis K, Stachteas P, et al
    Safety and efficacy of the new, oral, small-molecule, GLP-1 receptor agonists orforglipron and danuglipron for the treatment of type 2 diabetes and obesity: systematic review and meta-analysis of randomized controlled trials.
    Metabolism. 2023 Oct 16:155710. doi: 10.1016/j.metabol.2023.155710.
    >> Share

  64. TSUKAMOTO S, Suzuki T, Wakui H, Uehara T, et al
    Angiotensin II type 1 receptor-associated protein in immune cells: a possible key factor in the pathogenesis of visceral obesity.
    Metabolism. 2023;149:155706.
    >> Share

  65. ULLAH R, Shen Y, Zhou YD, Fu J, et al
    Perinatal metabolic inflammation in the hypothalamus impairs the development of homeostatic feeding circuitry.
    Metabolism. 2023;147:155677.
    >> Share

    September 2023
  66. KOKKORAKIS M, Katsarou A, Katsiki N, Mantzoros CS, et al
    Milestones in the journey towards addressing obesity; Past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery.
    Metabolism. 2023;148:155689.
    >> Share

  67. CHEN W, Cui W, Wu J, Zheng W, et al
    Blocking IL-6 signaling improves glucose tolerance via SLC39A5-mediated suppression of glucagon secretion.
    Metabolism. 2023;146:155641.
    >> Share

    August 2023
  68. POLYZOS SA, Vachliotis ID, Mantzoros CS
    Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
    Metabolism. 2023 Aug 4:155676. doi: 10.1016/j.metabol.2023.155676.
    >> Share

  69. HOFFMANN A, Meir AY, Hagemann T, Czechowski P, et al
    A polyphenol-rich green Mediterranean diet enhances epigenetic regulatory potential: the DIRECT PLUS randomized controlled trial.
    Metabolism. 2023;145:155594.
    >> Share

  70. PARK SH, Helsley RN, Fadhul T, Willoughby JLS, et al
    Fructose induced KHK-C can increase ER stress independent of its effect on lipogenesis to drive liver disease in diet-induced and genetic models of NAFLD.
    Metabolism. 2023;145:155591.
    >> Share

    July 2023
  71. FERNANDEZ-SAEZ EM, Losarcos M, Becerril S, Valenti V, et al
    Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD.
    Metabolism. 2023 Jul 28:155663. doi: 10.1016/j.metabol.2023.155663.
    >> Share

  72. MUTURI HT, Ghadieh HE, Abdolahipour R, Stankus HL, et al
    Loss of CEACAM1 in endothelial cells causes hepatic fibrosis.
    Metabolism. 2023;144:155562.
    >> Share

    June 2023
  73. KOSCHKER AC, Warrings B, Morbach C, Seyfried F, et al
    Effect of bariatric surgery on cardio-psycho-metabolic outcomes in severe obesity: A randomized controlled trial.
    Metabolism. 2023 Jun 30:155655. doi: 10.1016/j.metabol.2023.155655.
    >> Share

  74. JUNG EJ, Sung KW, Bae TH, Kim HY, et al
    The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD.
    Metabolism. 2023 Jun 27:155644. doi: 10.1016/j.metabol.2023.155644.
    >> Share

  75. AXELROD CL, Dantas WS, Kirwan JP
    Sarcopenic obesity: emerging mechanisms and therapeutic potential.
    Metabolism. 2023 Jun 26:155639. doi: 10.1016/j.metabol.2023.155639.
    >> Share

  76. WEI F, Gu Y, He L, Kapoor A, et al
    HSD17B6 delays type 2 diabetes development via inhibiting SREBP activation.
    Metabolism. 2023;145:155631.
    >> Share

  77. BOUTARI C, Hill MA, Procaccini C, Matarese G, et al
    The key role of inflammation in the pathogenesis and management of obesity and CVD.
    Metabolism. 2023 Jun 9:155627. doi: 10.1016/j.metabol.2023.155627.
    >> Share

  78. OH J, Park C, Kim S, Kim M, et al
    High levels of intracellular endotrophin in adipocytes mediate COPII vesicle supplies to autophagosome to impair autophagic flux and contribute to systemic insulin resistance in obesity.
    Metabolism. 2023 Jun 9:155629. doi: 10.1016/j.metabol.2023.155629.
    >> Share

  79. DE OLIVEIRA MC, Silveira ALM, de Oliveira ACC, Lana JP, et al
    Eosinophils protect from metabolic alterations triggered by obesity.
    Metabolism. 2023 Jun 7:155613. doi: 10.1016/j.metabol.2023.155613.
    >> Share

  80. LIU B, Zhong Y, Huang D, Yang L, et al
    LncRNA Nron deficiency protects mice from diet-induced adiposity and hepatic steatosis.
    Metabolism. 2023 Jun 3:155609. doi: 10.1016/j.metabol.2023.155609.
    >> Share

  81. WANG H, Xiong Q, He G, Tang J, et al
    Hepatic IDH2 regulates glycolysis and gluconeogenesis.
    Metabolism. 2023;143:155559.
    >> Share

  82. BARAZZONI R, Cederholm T, Zanetti M, Gortan Cappellari G, et al
    Defining and diagnosing sarcopenia: Is the glass now half full?
    Metabolism. 2023;143:155558.
    >> Share

  83. BRETHVAD AO, Zakariassen HL, Holt J, Lundgren JR, et al
    Increased meal-induced neurotensin response predicts successful maintenance of weight loss - Data from a randomized controlled trial.
    Metabolism. 2023;143:155534.
    >> Share

    May 2023
  84. CAPPELLARI GG, Semolic A, Zanetti M, Vinci P, et al
    Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.
    Metabolism. 2023 May 26:155595. doi: 10.1016/j.metabol.2023.155595.
    >> Share

  85. JAVAID HMA, Ko E, Joo EJ, Kwon SH, et al
    TNFalpha-induced NLRP3 inflammasome mediates adipocyte dysfunction and activates macrophages through adipocyte-derived lipocalin 2.
    Metabolism. 2023;142:155527.
    >> Share

    April 2023
  86. PARK MJ, Choi KM
    Interplay of skeletal muscle and adipose tissue: sarcopenic obesity.
    Metabolism. 2023 Apr 29:155577. doi: 10.1016/j.metabol.2023.155577.
    >> Share

  87. GUO X, Hu J, He G, Chen J, et al
    Loss of APOO (MIC26) aggravates obesity-related whitening of brown adipose tissue via PPARalpha-mediated functional interplay between mitochondria and peroxisomes.
    Metabolism. 2023 Apr 21:155564. doi: 10.1016/j.metabol.2023.155564.
    >> Share

  88. CHONG B, Kong G, Shankar K, Chew HSJ, et al
    The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000-2019.
    Metabolism. 2023;141:155402.
    >> Share

  89. REBELOS E, Mari A, Oikonen V, Iida H, et al
    Evaluation of renal glucose uptake with [(18)F]FDG-PET: Methodological advancements and metabolic outcomes.
    Metabolism. 2023;141:155382.
    >> Share

    March 2023
  90. PAPADOPOULOS G, Legaki AI, Georgila K, Vorkas P, et al
    Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.
    Metabolism. 2023 Mar 28:155552. doi: 10.1016/j.metabol.2023.155552.
    >> Share

  91. BIANZANO S, Henrich A, Herich L, Kalsch B, et al
    Efficacy and safety of the ghrelin-O-acyltransferase inhibitor BI 1356225 in overweight/obesity: Data from two Phase I, randomised, placebo-controlled studies.
    Metabolism. 2023 Mar 21:155550. doi: 10.1016/j.metabol.2023.155550.
    >> Share

  92. XU H, Yu W, Sun M, Bi Y, et al
    Syntaxin17 contributes to obesity cardiomyopathy through promoting mitochondrial Ca(2+) overload in a Parkin-MCUb-dependent manner.
    Metabolism. 2023 Mar 20:155551. doi: 10.1016/j.metabol.2023.155551.
    >> Share

  93. LUO X, Li Z, Chen L, Zhang X, et al
    Monocarboxylate transporter 1 in the liver modulates high-fat diet-induced obesity and hepatic steatosis in mice.
    Metabolism. 2023 Mar 16:155537. doi: 10.1016/j.metabol.2023.155537.
    >> Share

  94. MARLENE C, Christos MS
    Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy.
    Metabolism. 2023 Mar 2:155531. doi: 10.1016/j.metabol.2023.155531.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016